Assess the effects of pivekimab sunirine on spatial response in blastic plasmacytoid dendritic cell neoplasm and identify underlying resistance mechanisms.
Evaluated spatial response in blastic plasmacytoid dendritic cell neoplasm samples
Investigated potential resistance mechanisms to pivekimab sunirine
Analyzed immune response variations across different treatment conditions
Demonstrated effective spatial response to pivekimab sunirine in certain tumor areas
Identified specific resistance mechanisms that hinder treatment efficacy
Highlighted variations in immune response which may influence treatment outcomes